Nemysis Limited

Enteralia Bioscience SRL Acquires TFarma to Strengthen Presence in Italy’s Nutraceutical and Medical Device Market

Nemysis Limited is pleased to announce the successful acquisition of TFarma SRL ("TFarma") by its wholly-owned subsidiary, Enteralia Bioscience SRL ("Enteralia").

Nemysis is pleased to announce the further strengthening of its IP portfolio in relation to its unique and innovative nanoparticulate oral iron supplement, IHAT (Iron Hydroxide Adipate Tartrate), for the safe treatment of iron deficiency and iron deficiency anaemia.

Nemysis Ltd and Bruno Farmaceutici SpA are pleased to announce they have signed a non-exclusive sales and marketing agreement for IHAT (Iron Hydroxide Adipate Tartrate), Nemysis' innovative oral iron supplementation product.

Nemysis has entered into Heads of Terms for two nonexclusive sales and marketing agreements with two potential partners for the sale and marketing of its IHAT product within the Italian market.